Novocure (NASDAQ: NVCR) reported Q3 EPS of ($0.25), $0.01 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $130.99 million versus the consensus estimate of $132.42 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.